InVivo Therapeutics Holdings Corp. (NVIVQ) Financial Statements (2024 and earlier)

Company Profile

Business Address ONE KENDALL SQUARE
CAMBRIDGE, MA 02139
State of Incorp. NV
Fiscal Year End December 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) (USD)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments16,351,00019,031,00019,493,0006,602,00016,660,00012,910,000
Cash and cash equivalents16,351,00019,031,00019,493,0006,602,00016,660,00012,910,000
Restricted cash and investments    4,0004,000361,000
Prepaid expense97,000   17,000 
Other current assets1,153,000     
Other undisclosed current assets  111,000163,000177,000444,000535,000
Total current assets:17,601,00019,142,00019,656,0006,783,00017,125,00013,806,000
Noncurrent Assets
Operating lease, right-of-use asset 844,0001,229,000928,0001,211,000
Property, plant and equipment227,000127,00085,00073,000100,000157,000
Prepaid expense  1,122,0001,122,0001,122,000  
Restricted cash and investments150,000150,000110,000110,000110,000 
Other noncurrent assets   9,00026,0001,042,00082,000
Total noncurrent assets:1,221,0002,628,0002,254,0002,542,0001,252,000239,000
TOTAL ASSETS:18,822,00021,770,00021,910,0009,325,00018,377,00014,045,000
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities2,072,0002,251,0001,645,0002,369,0002,105,0002,626,000
Accounts payable617,000605,000481,000942,000815,000988,000
Accrued liabilities1,455,0001,646,0001,164,0001,427,0001,290,0001,638,000
Debt    294,000100,000452,000
Derivative instruments and hedges, liabilities      4,000
Deferred revenue and credits30,000
Other undisclosed current liabilities 396,000361,000327,000   
Total current liabilities:2,468,0002,612,0001,972,0002,663,0002,205,0003,112,000
Noncurrent Liabilities
Long-term debt and lease obligation  949,000693,0001,020,000 400,000
Long-term debt, excluding current maturities      400,000
Liabilities, other than long-term debt 608,00094,00059,00059,00061,000423,000
Deferred revenue and credits367,000
Other liabilities 55,00094,00059,00059,00061,00056,000
Operating lease, liability 553,000949,000693,0001,020,000
Total noncurrent liabilities: 608,0001,043,000752,0001,079,00061,000823,000
Total liabilities:3,076,0003,655,0002,724,0003,742,0002,266,0003,935,000
Equity
Equity, attributable to parent15,746,00018,115,00019,186,0005,583,00016,111,00010,110,000
Common stock3,0003,0003,0002,0001,0001,000
Additional paid in capital264,362,000256,241,000247,417,000224,741,000223,440,000194,016,000
Accumulated deficit(248,619,000)(238,129,000)(228,234,000)(219,160,000)(207,330,000)(183,907,000)
Total equity:15,746,00018,115,00019,186,0005,583,00016,111,00010,110,000
TOTAL LIABILITIES AND EQUITY:18,822,00021,770,00021,910,0009,325,00018,377,00014,045,000

Income Statement (P&L) (USD)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Operating expenses(10,650,000)(9,900,000)(9,097,000)(11,497,000)(12,767,000)(24,593,000)
Operating loss:(10,650,000)(9,900,000)(9,097,000)(11,497,000)(12,767,000)(24,593,000)
Nonoperating income (expense)160,0005,00023,000(333,000)(10,656,000)(2,152,000)
Investment income, nonoperating     (12,165,000) 
Other nonoperating income (expense)9,0002,0004,000(587,000)1,303,000(2,152,000)
Interest and debt expense      (74,000)
Loss from continuing operations:(10,490,000)(9,895,000)(9,074,000)(11,830,000)(23,423,000)(26,819,000)
Loss before gain (loss) on sale of properties:(9,895,000)(9,074,000)(11,830,000)(23,423,000)(26,819,000)
Other undisclosed net income      74,000
Net loss available to common stockholders, diluted:(10,490,000)(9,895,000)(9,074,000)(11,830,000)(23,423,000)(26,745,000)

Comprehensive Income (USD)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net loss:(10,490,000)(9,895,000)(9,074,000)(11,830,000)(23,423,000)(26,745,000)
Comprehensive loss, net of tax, attributable to parent:(10,490,000)(9,895,000)(9,074,000)(11,830,000)(23,423,000)(26,745,000)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: